Autor: "Nilsson, Peter M." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: A nutritional biomarker score of the Mediterranean diet and incident type 2 diabetes: Integrated analysis of data from the MedLey randomised controlled trial and the EPIC-InterAct case-cohort study.
Autorzy:: Sobiecki JG; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Imamura F; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Davis CR; Alliance for Research in Exercise, Nutrition and Activity, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia.
Sharp SJ; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Koulman A; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, United Kingdom.; Nutritional Biomarker Laboratory, National Institute for Health Research Biomedical Research Centre, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Hodgson JM; Nutrition & Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.; Medical School, University of Western Australia, Perth, Australia.
Guevara M; Navarra Public Health Institute, Pamplona, Spain.; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
Schulze MB; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.; German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.
Zheng JS; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, United Kingdom.; Key Laboratory of Growth Regulation and Translation Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.
Agnoli C; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.
Bonet C; Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L'Hospitalet de Llobregat, Barcelona, Spain.; Nutrition and Cancer Group, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Colorado-Yohar SM; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.; Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín, Colombia.
Fagherazzi G; Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Insitute of Health, Strassen, Luxembourg.; Center of Epidemiology and Population Health UMR 1018, Inserm, Paris South-Paris Saclay University, Gustave Roussy Institute, Villejuif, France.
Franks PW; Department of Clinical Sciences, Lund University, Malmö, Sweden.
Gundersen TE; Vitas AS, Oslo, Norway.
Jannasch F; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.; German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.
Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Katzke V; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Molina-Montes E; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Institute of Nutrition and Food Technology (INYTA) 'José Mataix', Biomedical Research Centre, University of Granada, Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Department of Nutrition and Food Science, University of Granada, Granada, Spain.
Nilsson PM; Department of Clinical Sciences, Lund University, Malmö, Sweden.
Palli D; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy.
Panico S; Department of Mental, Physical Health and Preventive Medicine, University 'L. Vanvitelli', Naples, Italy.
Papier K; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Rolandsson O; Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden.
Sacerdote C; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin, Italy.
Tjønneland A; Danish Cancer Society Research Center, Copenhagen, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Tong TYN; Department of Mental, Physical Health and Preventive Medicine, University 'L. Vanvitelli', Naples, Italy.
van der Schouw YT; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Danesh J; BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; British Heart Foundation Cambridge Centre of Excellence, Division of Cardiovascular Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom.; Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.; Health Data Research UK Cambridge, University of Cambridge, Cambridge, United Kingdom.
Butterworth AS; BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Riboli E; School of Public Health, Imperial College London, London, United Kingdom.
Murphy KJ; Alliance for Research in Exercise, Nutrition and Activity, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia.
Wareham NJ; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Forouhi NG; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, United Kingdom.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2023 Apr 27; Vol. 20 (4), pp. e1004221. Date of Electronic Publication: 2023 Apr 27 (Print Publication: 2023).
Typ publikacji:: Randomized Controlled Trial; Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Diet, Mediterranean*
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/prevention & control
Neoplasms*/complications
Adult ; Humans ; Australia ; Cohort Studies ; Biomarkers ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: A healthy dietary metabolic signature is associated with a lower risk for type 2 diabetes and coronary artery disease.
Autorzy:: Smith E; Department of Clinical Sciences, Lund University, Jan Waldenströms gata 35, 91-12-027, SE-214 28, Malmö, Sweden. .
Ericson U; Department of Clinical Sciences, Lund University, Jan Waldenströms gata 35, 91-12-027, SE-214 28, Malmö, Sweden.
Hellstrand S; Department of Clinical Sciences, Lund University, Jan Waldenströms gata 35, 91-12-027, SE-214 28, Malmö, Sweden.
Orho-Melander M; Department of Clinical Sciences, Lund University, Jan Waldenströms gata 35, 91-12-027, SE-214 28, Malmö, Sweden.
Nilsson PM; Department of Clinical Sciences, Lund University, Jan Waldenströms gata 35, 91-12-027, SE-214 28, Malmö, Sweden.; Department of Emergency and Internal Medicine, Skåne University Hospital, Malmö, Sweden.
Fernandez C; Department of Clinical Sciences, Lund University, Jan Waldenströms gata 35, 91-12-027, SE-214 28, Malmö, Sweden.
Melander O; Department of Clinical Sciences, Lund University, Jan Waldenströms gata 35, 91-12-027, SE-214 28, Malmö, Sweden.; Department of Emergency and Internal Medicine, Skåne University Hospital, Malmö, Sweden.
Ottosson F; Department of Clinical Sciences, Lund University, Jan Waldenströms gata 35, 91-12-027, SE-214 28, Malmö, Sweden.; Section for Clinical Mass Spectrometry, Danish Center for Neonatal Screening, Department of Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2022 Apr 21; Vol. 20 (1), pp. 122. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Coronary Artery Disease*/epidemiology
Diabetes Mellitus, Type 2*/epidemiology
Biomarkers ; Diet ; Humans ; Prospective Studies ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The association between circulating 25-hydroxyvitamin D metabolites and type 2 diabetes in European populations: A meta-analysis and Mendelian randomisation analysis.
Autorzy:: Zheng JS; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.; Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.
Luan J; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Sofianopoulou E; MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Sharp SJ; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Day FR; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Imamura F; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Gundersen TE; VITAS, Oslo, Norway.
Lotta LA; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Sluijs I; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Stewart ID; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Shah RL; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
van der Schouw YT; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Wheeler E; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Ardanaz E; Navarra Public Health Institute, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Boeing H; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Germany.
Dorronsoro M; Public Health Division of Gipuzkoa, San Sebastian, Spain.
Dahm CC; Department of Public Health, Aarhus University, Aarhus, Denmark.
Dimou N; International Agency for Research on Cancer, Lyon, France.
El-Fatouhi D; Center of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris South-Paris Saclay University, Villejuif, France.
Franks PW; Department of Clinical Sciences, Lund University, Malmö, Sweden.
Fagherazzi G; Center of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris South-Paris Saclay University, Villejuif, France.; Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg.
Grioni S; Epidemiology and Prevention Unit, Milan, Italy.
Huerta JM; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Epidemiology, Murcia Regional Health Council, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca, Murcia, Spain.
Heath AK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Hansen L; Danish Cancer Society Research Center, Copenhagen, Denmark.
Jenab M; International Agency for Research on Cancer, Lyon, France.
Jakszyn P; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-Institut d'Investigació Biomédica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Facultat Ciències Salut Blanquerna, Universitat Ramon Llull, Barcelona, Spain.
Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kühn T; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Khaw KT; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Laouali N; Center of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris South-Paris Saclay University, Villejuif, France.
Masala G; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Nilsson PM; Department of Clinical Sciences, Lund University, Malmö, Sweden.
Overvad K; Department of Public Health, Aarhus University, Aarhus, Denmark.; Department of Cardiology, Aalborg University Hospital, Aarhus, Denmark.
Olsen A; Danish Cancer Society Research Center, Copenhagen, Denmark.
Panico S; Dipartimento di Medicina Clinica e Chirurgia, University of Naples Federico II, Naples, Italy.
Quirós JR; Public Health Directorate, Asturias, Spain.
Rolandsson O; Family Medicine Division, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Rodríguez-Barranco M; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Andalusian School of Public Health (EASP), Granada, Spain.; Instituto de Investigación Biosanitaria de Granada, Universidad de Granada, Granada, Spain.
Sacerdote C; Unit of Cancer Epidemiology, Città della Salute e della Scienza di Torino University Hospital-University of Turin and Center for Cancer Prevention (CPO), Torino, Italy.
Spijkerman AMW; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Tong TYN; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Tumino R; Azienda Sanitaria Provinciale, Ragusa, Italy.
Tsilidis KK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
Danesh J; MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; British Heart Foundation Cambridge Centre of Excellence, Division of Cardiovascular Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom.; Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom.
Riboli E; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Butterworth AS; MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Langenberg C; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Forouhi NG; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Wareham NJ; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2020 Oct 16; Vol. 17 (10), pp. e1003394. Date of Electronic Publication: 2020 Oct 16 (Print Publication: 2020).
Typ publikacji:: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus, Type 2/*metabolism
Vitamin D/*analogs & derivatives
Adult ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/etiology ; Dietary Supplements ; Female ; Genome-Wide Association Study ; Humans ; Male ; Mendelian Randomization Analysis/methods ; Middle Aged ; Prospective Studies ; Risk Factors ; Vitamin D/analysis ; Vitamin D/blood ; Vitamin D/metabolism ; White People/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Food patterns in relation to weight change and incidence of type 2 diabetes, coronary events and stroke in the Malmö Diet and Cancer cohort.
Autorzy:: Ericson U; Department of Clinical Sciences in Malmö, Diabetes and Cardiovascular Disease, Genetic Epidemiology, Lund University, Malmö, Sweden. .; Clinical Research Centre, building 60, floor 13, SUS in Malmö, entrance 72, Jan Waldenströms gata 35, 205 02, Malmö, Sweden. .
Brunkwall L; Department of Clinical Sciences in Malmö, Diabetes and Cardiovascular Disease, Genetic Epidemiology, Lund University, Malmö, Sweden.
Alves Dias J; Department of Clinical Sciences in Malmö, Nutritional Epidemiology, Lund University, Malmö, Sweden.
Drake I; Department of Clinical Sciences in Malmö, Diabetes and Cardiovascular Disease, Genetic Epidemiology, Lund University, Malmö, Sweden.
Hellstrand S; Department of Clinical Sciences in Malmö, Diabetes and Cardiovascular Disease, Genetic Epidemiology, Lund University, Malmö, Sweden.
Gullberg B; Department of Clinical Sciences in Malmö, Nutritional Epidemiology, Lund University, Malmö, Sweden.
Sonestedt E; Department of Clinical Sciences in Malmö, Nutritional Epidemiology, Lund University, Malmö, Sweden.
Nilsson PM; Department of Internal Medicine, Skåne University Hospital, Lund University, Malmö, Sweden.
Wirfält E; Department of Clinical Sciences in Malmö, Nutritional Epidemiology, Lund University, Malmö, Sweden.
Orho-Melander M; Department of Clinical Sciences in Malmö, Diabetes and Cardiovascular Disease, Genetic Epidemiology, Lund University, Malmö, Sweden.; Pokaż więcej
Źródło:: European journal of nutrition [Eur J Nutr] 2019 Aug; Vol. 58 (5), pp. 1801-1814. Date of Electronic Publication: 2018 May 31.
Typ publikacji:: Journal Article
MeSH Terms:: Coronary Disease/*epidemiology
Diabetes Mellitus, Type 2/*epidemiology
Diet/*methods
Stroke/*epidemiology
Weight Gain/*physiology
Aged ; Cohort Studies ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Middle Aged ; Principal Component Analysis ; Prospective Studies ; Sweden/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Using a Targeted Proteomics Chip to Explore Pathophysiological Pathways for Incident Diabetes- The Malmö Preventive Project.
Autorzy:: Molvin J; Department of Clinical Sciences, Lund University, Clinical Research Center, Malmö, Sweden. .; Department of Cardiology, Skåne University Hospital Malmö, Malmö, Sweden. .
Pareek M; Cardiology Section, Department of Internal Medicine, Holbæk Hospital, Holbæk, Denmark.; Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, Massachusetts, USA.
Jujic A; Department of Clinical Sciences, Lund University, Clinical Research Center, Malmö, Sweden.
Melander O; Department of Clinical Sciences, Lund University, Clinical Research Center, Malmö, Sweden.; Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden.
Råstam L; Department of Clinical Sciences, Lund University, Clinical Research Center, Malmö, Sweden.
Lindblad U; Institute of Medicine, Department of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Daka B; Institute of Medicine, Department of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Leósdóttir M; Department of Clinical Sciences, Lund University, Clinical Research Center, Malmö, Sweden.; Department of Cardiology, Skåne University Hospital Malmö, Malmö, Sweden.
Nilsson PM; Department of Clinical Sciences, Lund University, Clinical Research Center, Malmö, Sweden.; Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden.
Olsen MH; Cardiology Section, Department of Internal Medicine, Holbæk Hospital, Holbæk, Denmark.; Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, University of Southern Denmark, Odense, Denmark.
Magnusson M; Department of Clinical Sciences, Lund University, Clinical Research Center, Malmö, Sweden.; Department of Cardiology, Skåne University Hospital Malmö, Malmö, Sweden.; Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2019 Jan 22; Vol. 9 (1), pp. 272. Date of Electronic Publication: 2019 Jan 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus, Type 2/*diagnosis
Proteomics/*methods
Aged ; Biomarkers/blood ; Blood Glucose/analysis ; Case-Control Studies ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/etiology ; Female ; Humans ; Immunoassay/instrumentation ; Immunoassay/methods ; Incidence ; Male ; Middle Aged ; Prognosis ; Proteomics/instrumentation ; Risk Factors ; Sweden/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Prognostic impact of systolic blood pressure variability in people with diabetes.
Autorzy:: Bell KJL; Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Azizi L; School of Mathematics and Statistics, University of Sydney, Sydney, New South Wales, Australia.
Nilsson PM; Department of Clinical Sciences, Lund University, Malmo, University Hospital, Malmo, Sweden.
Hayen A; Australian Centre for Public and Population Health Research University of Technology Sydney (UTS), Sydney, New South Wales, Australia.
Irwig L; Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Östgren CJ; Department of Medical and Health Sciences, Linkoping University, Linkoping, Sweden.
Sundröm J; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2018 Apr 11; Vol. 13 (4), pp. e0194084. Date of Electronic Publication: 2018 Apr 11 (Print Publication: 2018).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Blood Pressure/*physiology
Cardiovascular Diseases/*mortality
Diabetes Mellitus, Type 2/*physiopathology
Hypertension/*mortality
Aged ; Blood Pressure Determination ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/physiopathology ; Diabetes Mellitus, Type 2/complications ; Female ; Humans ; Hypertension/etiology ; Hypertension/physiopathology ; Male ; Middle Aged ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study.
Autorzy:: Imamura F; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Sharp SJ; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Koulman A; National Institute for Health Research Biomedical Research Centres Core Nutritional Biomarker Laboratory, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.; National Institute for Health Research Biomedical Research Centres Core Metabolomics and Lipidomics Laboratory, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.; Medical Research Council Epidemiology Unit Elsie Widdowson Laboratory, Cambridge, United Kingdom.
Schulze MB; Department of Molecular Epidemiology, German Institute of Human Nutrition, Potsdam, Germany.
Kröger J; Department of Molecular Epidemiology, German Institute of Human Nutrition, Potsdam, Germany.
Griffin JL; Medical Research Council Epidemiology Unit Elsie Widdowson Laboratory, Cambridge, United Kingdom.; Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Huerta JM; Department of Epidemiology, Consejería de Sanidad y Política Social, CIBER de Epidemiología y Salud Pública, Murcia, Spain.; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Guevara M; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Navarre Public Health Institute, Pamplona, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
Sluijs I; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Agudo A; Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Barcelona, Spain.
Ardanaz E; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Navarre Public Health Institute, Pamplona, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
Balkau B; Center for Research in Epidemiology and Population Health, Inserm U1018, Paris-Sud University, University Versailles Saint-Quentin-en-Yvelines, Paris Saclay University, Villejuif, France.
Boeing H; Department of Molecular Epidemiology, German Institute of Human Nutrition, Potsdam, Germany.
Chajes V; International Agency for Research on Cancer, Lyon, France.
Dahm CC; Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Dow C; Center for Research in Epidemiology and Population Health, Inserm U1018, Paris-Sud University, University Versailles Saint-Quentin-en-Yvelines, Paris Saclay University, Villejuif, France.; Gustave Roussy Institute, Villejuif, France.
Fagherazzi G; Center for Research in Epidemiology and Population Health, Inserm U1018, Paris-Sud University, University Versailles Saint-Quentin-en-Yvelines, Paris Saclay University, Villejuif, France.; Gustave Roussy Institute, Villejuif, France.
Feskens EJM; Department of Agrotechnology and Food Sciences, Wageningen University, Wageningen, Netherlands.
Franks PW; Family Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.; Department of Clinical Sciences, Lund University, Skane University Hospital, Malmo, Sweden.
Gavrila D; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain.; Murcia BioHealth Research Institute-Hospital Virgen de la Arrixaca, Murcia, Spain.
Gunter M; Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Key TJ; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Khaw KT; Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Kühn T; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Melander O; Department of Clinical Sciences, Lund University, Skane University Hospital, Malmo, Sweden.
Molina-Portillo E; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
Nilsson PM; Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Olsen A; Danish Cancer Society Research Center, Copenhagen, Denmark.
Overvad K; Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.; Department of Cardiology, Aalborg University Hospital, Aarhus, Denmark.
Palli D; Cancer Risk Factors and Lifestyle Epidemiology Unit, Cancer Research and Prevention Institute, Florence, Italy.
Panico S; Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Federico II University, Naples, Italy.
Rolandsson O; Family Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Sieri S; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Sacerdote C; Unit of Cancer Epidemiology, Città della Salute e della Scienza Hospital-University of Turin and Center for Cancer Prevention, Torino, Italy.
Slimani N; International Agency for Research on Cancer, Lyon, France.
Spijkerman AMW; National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Tjønneland A; Danish Cancer Society Research Center, Copenhagen, Denmark.
Tumino R; Affiliation Cancer Registry, Department of Prevention, Azienda Sanitaria Provinciale di Ragusa, Ragusa, Italy.
van der Schouw YT; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Langenberg C; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Riboli E; School of Public Health, Imperial College London, London, United Kingdom.
Forouhi NG; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Wareham NJ; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2017 Oct 11; Vol. 14 (10), pp. e1002409. Date of Electronic Publication: 2017 Oct 11 (Print Publication: 2017).
Typ publikacji:: Journal Article
MeSH Terms:: Internationality*
Diabetes Mellitus, Type 2/*blood
Diabetes Mellitus, Type 2/*epidemiology
Fatty Acids/*blood
Phospholipids/*blood
Biomarkers/blood ; Case-Control Studies ; Cohort Studies ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/diagnosis ; Europe/epidemiology ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Principal Component Analysis/methods ; Prospective Studies ; Random Allocation

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Aortic diameter at age 65 in men with newly diagnosed type 2 diabetes.
Autorzy:: Taimour S; a Department of Vascular Diseases , Lund University, Skåne University Hospital , Malmö , Sweden.
Zarrouk M; a Department of Vascular Diseases , Lund University, Skåne University Hospital , Malmö , Sweden.
Holst J; a Department of Vascular Diseases , Lund University, Skåne University Hospital , Malmö , Sweden.
Rosengren AH; b Department of Neuroscience and Physiology , University of Gothenburg , Gothenburg , Sweden.; c Department of Internal Medicine , Clinical Research Unit, Skåne University Hospital , Malmö , Sweden.
Groop L; c Department of Internal Medicine , Clinical Research Unit, Skåne University Hospital , Malmö , Sweden.
Nilsson PM; c Department of Internal Medicine , Clinical Research Unit, Skåne University Hospital , Malmö , Sweden.
Gottsäter A; a Department of Vascular Diseases , Lund University, Skåne University Hospital , Malmö , Sweden.; Pokaż więcej
Źródło:: Scandinavian cardiovascular journal : SCJ [Scand Cardiovasc J] 2017 Aug; Vol. 51 (4), pp. 202-206. Date of Electronic Publication: 2017 Apr 24.
Typ publikacji:: Journal Article
MeSH Terms:: Aorta, Abdominal*/diagnostic imaging
Aortic Aneurysm, Abdominal/*epidemiology
Diabetes Mellitus, Type 2/*epidemiology
Aged ; Aortic Aneurysm, Abdominal/diagnostic imaging ; Aortic Aneurysm, Abdominal/prevention & control ; Chi-Square Distribution ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/diagnosis ; Diabetes Mellitus, Type 2/prevention & control ; Dilatation, Pathologic ; Humans ; Logistic Models ; Male ; Multivariate Analysis ; Prevalence ; Protective Factors ; Risk Factors ; Sweden/epidemiology ; Ultrasonography

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.
Autorzy:: Forouhi NG; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Imamura F; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Sharp SJ; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Koulman A; MRC Human Nutrition Research, Cambridge, UK.
Schulze MB; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Germany.
Zheng J; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Ye Z; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Sluijs I; University Medical Center Utrecht, Utrecht, the Netherlands.
Guevara M; Navarre Public Health Institute (ISPN), Pamplona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.
Huerta JM; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Kröger J; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Germany.
Wang LY; MRC Human Nutrition Research, Cambridge, UK.
Summerhill K; MRC Human Nutrition Research, Cambridge, UK.
Griffin JL; MRC Human Nutrition Research, Cambridge, UK.
Feskens EJ; Wageningen University, The Netherlands.
Affret A; Inserm, CESP, U1018, Villejuif, France.; Univ Paris-Sud, UMRS 1018, Villejuif, France.; Gustave Roussy Institute, Villejuif, France.
Amiano P; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Public Health Division of Gipuzkoa, San Sebastian, Spain.; Instituto BIO-Donostia, Basque Government, San Sebastian, Spain.
Boeing H; German Institute of Human Nutrition Potsdam-Rehbruecke, Germany.
Dow C; Inserm, CESP, U1018, Villejuif, France.; Univ Paris-Sud, UMRS 1018, Villejuif, France.; Gustave Roussy Institute, Villejuif, France.
Fagherazzi G; Inserm, CESP, U1018, Villejuif, France.; Univ Paris-Sud, UMRS 1018, Villejuif, France.; Gustave Roussy Institute, Villejuif, France.
Franks PW; Lund University, Malmö, Sweden.; Umeå University, Umeå, Sweden.
Gonzalez C; Catalan Institute of Oncology (ICO), Barcelona, Spain.
Kaaks R; German Cancer Research Centre (DKFZ), Heidelberg, Germany.
Key TJ; University of Oxford, Oxford, United Kingdom.
Khaw KT; University of Cambridge, Cambridge, United Kingdom.
Kühn T; German Cancer Research Centre (DKFZ), Heidelberg, Germany.
Mortensen LM; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.; Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
Nilsson PM; Lund University, Malmö, Sweden.
Overvad K; Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.; Aalborg University Hospital, Aalborg, Denmark.
Pala V; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Palli D; Cancer Research and Prevention Institute (ISPO), Florence, Italy.
Panico S; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
Quirós JR; Public Health Directorate, Asturias, Spain.
Rodriguez-Barranco M; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA. Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
Rolandsson O; Umeå University, Umeå, Sweden.
Sacerdote C; Unit of Cancer Epidemiology, Citta' della Salute e della Scienza Hospital-University of Turin and Center for Cancer Prevention (CPO), Turin, Italy.; Human Genetics Foundation (HuGeF), Turin, Italy.
Scalbert A; International Agency for Research on Cancer, Lyon, France.
Slimani N; International Agency for Research on Cancer, Lyon, France.
Spijkerman AM; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Tjonneland A; Danish Cancer Society Research Center, Copenhagen, Denmark.
Tormo MJ; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain.
Tumino R; Cancer Registry and Histopathology Unit, Civic and M.P.Arezzo Hospital, ASP Ragusa, Italy.
van der A DL; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van der Schouw YT; University Medical Center Utrecht, Utrecht, the Netherlands.
Langenberg C; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Riboli E; School of Public Health, Imperial College London, London, United Kingdom.
Wareham NJ; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2016 Jul 19; Vol. 13 (7), pp. e1002094. Date of Electronic Publication: 2016 Jul 19 (Print Publication: 2016).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus, Type 2/*etiology
Fatty Acids, Omega-3/*blood
Fatty Acids, Omega-6/*blood
Fatty Acids, Unsaturated/*blood
Case-Control Studies ; Diabetes Mellitus, Type 2/blood ; Fatty Acids, Omega-3/adverse effects ; Fatty Acids, Omega-6/adverse effects ; Fatty Acids, Unsaturated/adverse effects ; Humans ; Male ; Middle Aged

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study.
Autorzy:: Grundvold I; Department of Cardiology, Oslo University Hospital, Ullevaal, PB 4956, Nydalen, 0424, Oslo, Norway. .
Bodegard J; AstraZeneca Nordic, Södertälje, Sweden. .
Nilsson PM; Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden. peter.nilsson@med.lu.se.
Svennblad B; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. .
Johansson G; Department of Public health and Caring Science, Uppsala University, Uppsala, Sweden. .
Östgren CJ; Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. .
Sundström J; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. .; Department of Medical Sciences, Uppsala University, Uppsala, Sweden. .; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2015 Jan 15; Vol. 14, pp. 5. Date of Electronic Publication: 2015 Jan 15.
Typ publikacji:: Clinical Trial; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Body Mass Index*
Body Weight*
Atrial Fibrillation/*diagnosis
Atrial Fibrillation/*epidemiology
Diabetes Mellitus, Type 2/*diagnosis
Diabetes Mellitus, Type 2/*epidemiology
Aged ; Cohort Studies ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study.
Autorzy:: Langenberg C; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Sharp SJ; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Franks PW; Lund University, Malmö, Sweden; Umeå University, Umeå, Sweden.
Scott RA; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Deloukas P; The Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
Forouhi NG; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Froguel P; Imperial College London, London, United Kingdom.
Groop LC; University Hospital Scania, Malmö, Sweden; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Hansen T; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Palla L; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Pedersen O; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Faculty of Health Science, University of Aarhus, Aarhus, Denmark; Institute of Biomedical Science, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Schulze MB; German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany.
Tormo MJ; Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain; Consorcio de Investigación Biomédica de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Department of Health and Social Sciences, Universidad de Murcia, Spain.
Wheeler E; The Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
Agnoli C; Epidemiology and Prevention Unit, Milan, Italy.
Arriola L; Consorcio de Investigación Biomédica de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Public Health Division of Gipuzkoa, San Sebastian, Spain; Instituto de Investigación Sanitaria BioDonostia, Basque Government, San Sebastian, Spain.
Barricarte A; Consorcio de Investigación Biomédica de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Navarre Public Health Institute, Pamplona, Spain.
Boeing H; German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany.
Clarke GM; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Clavel-Chapelon F; Inserm, CESP U1018, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France.
Duell EJ; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain.
Fagherazzi G; Inserm, CESP U1018, Villejuif, France; Université Paris-Sud, UMRS 1018, Villejuif, France.
Kaaks R; German Cancer Research Center, Heidelberg, Germany.
Kerrison ND; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Key TJ; University of Oxford, Oxford, United Kingdom.
Khaw KT; University of Cambridge, Cambridge, United Kingdom.
Kröger J; German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany.
Lajous M; Inserm, CESP U1018, Villejuif, France; Center for Research on Population Health, National Institute of Public Health of Mexico, Cuernavaca, Mexico; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Morris AP; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Navarro C; Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain; Consorcio de Investigación Biomédica de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Unit of Preventive Medicine and Public Health, School of Medicine, University of Murcia, Murcia, Spain.
Nilsson PM; Lund University, Malmö, Sweden.
Overvad K; Department of Public Health, Aarhus University, Aarhus, Denmark; Aalborg University Hospital, Aalborg, Denmark.
Palli D; Cancer Research and Prevention Institute, Florence, Italy.
Panico S; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
Quirós JR; Public Health Directorate, Asturias, Spain.
Rolandsson O; Umeå University, Umeå, Sweden.
Sacerdote C; Unit of Cancer Epidemiology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, University of Turin, Turin, Italy; Piedmont Reference Center for Epidemiology and Cancer Prevention, Torino, Italy; Human Genetics Foundation, Torino, Italy.
Sánchez MJ; Consorcio de Investigación Biomédica de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Andalusian School of Public Health, Granada, Spain.
Slimani N; International Agency for Research on Cancer, Lyon, France.
Spijkerman AM; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Tumino R; Azienda Sanitaria Provinciale di Ragusa, Ragusa, Italy; Aire Onlus, Ragusa, Italy.
van der A DL; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
van der Schouw YT; University Medical Center Utrecht, Utrecht, The Netherlands.
Barroso I; The Wellcome Trust Sanger Institute, Cambridge, United Kingdom; University of Cambridge Metabolic Research Laboratories, Cambridge, United Kingdom.
McCarthy MI; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.
Riboli E; School of Public Health, Imperial College London, London, United Kingdom.
Wareham NJ; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2014 May 20; Vol. 11 (5), pp. e1001647. Date of Electronic Publication: 2014 May 20 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Genetic Predisposition to Disease*
Life Style*
Diabetes Mellitus, Type 2/*genetics
Alleles ; Body Mass Index ; Cohort Studies ; Diabetes Mellitus, Type 2/diet therapy ; Diet, Mediterranean ; Female ; Humans ; Male ; Middle Aged ; Motor Activity ; Polymorphism, Single Nucleotide/genetics ; Proportional Hazards Models ; Risk Factors ; Waist Circumference/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.
Autorzy:: Mahajan A
Go MJ
Zhang W
Below JE
Gaulton KJ
Ferreira T
Horikoshi M
Johnson AD
Ng MC
Prokopenko I
Saleheen D
Wang X
Zeggini E
Abecasis GR
Adair LS
Almgren P
Atalay M
Aung T
Baldassarre D
Balkau B
Bao Y
Barnett AH
Barroso I
Basit A
Been LF
Beilby J
Bell GI
Benediktsson R
Bergman RN
Boehm BO
Boerwinkle E
Bonnycastle LL
Burtt N
Cai Q
Campbell H
Carey J
Cauchi S
Caulfield M
Chan JC
Chang LC
Chang TJ
Chang YC
Charpentier G
Chen CH
Chen H
Chen YT
Chia KS
Chidambaram M
Chines PS
Cho NH
Cho YM
Chuang LM
Collins FS
Cornelis MC
Couper DJ
Crenshaw AT
van Dam RM
Danesh J
Das D
de Faire U
Dedoussis G
Deloukas P
Dimas AS
Dina C
Doney AS
Donnelly PJ
Dorkhan M
van Duijn C
Dupuis J
Edkins S
Elliott P
Emilsson V
Erbel R
Eriksson JG
Escobedo J
Esko T
Eury E
Florez JC
Fontanillas P
Forouhi NG
Forsen T
Fox C
Fraser RM
Frayling TM
Froguel P
Frossard P
Gao Y
Gertow K
Gieger C
Gigante B
Grallert H
Grant GB
Grrop LC
Groves CJ
Grundberg E
Guiducci C
Hamsten A
Han BG
Hara K
Hassanali N
Hattersley AT
Hayward C
Hedman AK
Herder C
Hofman A
Holmen OL
Hovingh K
Hreidarsson AB
Hu C
Hu FB
Hui J
Humphries SE
Hunt SE
Hunter DJ
Hveem K
Hydrie ZI
Ikegami H
Illig T
Ingelsson E
Islam M
Isomaa B
Jackson AU
Jafar T
James A
Jia W
Jöckel KH
Jonsson A
Jowett JB
Kadowaki T
Kang HM
Kanoni S
Kao WH
Kathiresan S
Kato N
Katulanda P
Keinanen-Kiukaanniemi KM
Kelly AM
Khan H
Khaw KT
Khor CC
Kim HL
Kim S
Kim YJ
Kinnunen L
Klopp N
Kong A
Korpi-Hyövälti E
Kowlessur S
Kraft P
Kravic J
Kristensen MM
Krithika S
Kumar A
Kumate J
Kuusisto J
Kwak SH
Laakso M
Lagou V
Lakka TA
Langenberg C
Langford C
Lawrence R
Leander K
Lee JM
Lee NR
Li M
Li X
Li Y
Liang J
Liju S
Lim WY
Lind L
Lindgren CM
Lindholm E
Liu CT
Liu JJ
Lobbens S
Long J
Loos RJ
Lu W
Luan J
Lyssenko V
Ma RC
Maeda S
Mägi R
Männisto S
Matthews DR
Meigs JB
Melander O
Metspalu A
Meyer J
Mirza G
Mihailov E
Moebus S
Mohan V
Mohlke KL
Morris AD
Mühleisen TW
Müller-Nurasyid M
Musk B
Nakamura J
Nakashima E
Navarro P
Ng PK
Nica AC
Nilsson PM
Njølstad I
Nöthen MM
Ohnaka K
Ong TH
Owen KR
Palmer CN
Pankow JS
Park KS
Parkin M
Pechlivanis S
Pedersen NL
Peltonen L
Perry JR
Peters A
Pinidiyapathirage JM
Platou CG
Potter S
Price JF
Qi L
Radha V
Rallidis L
Rasheed A
Rathman W
Rauramaa R
Raychaudhuri S
Rayner NW
Rees SD
Rehnberg E
Ripatti S
Robertson N
Roden M
Rossin EJ
Rudan I
Rybin D
Saaristo TE
Salomaa V
Saltevo J
Samuel M
Sanghera DK
Saramies J
Scott J
Scott LJ
Scott RA
Segrè AV
Sehmi J
Sennblad B
Shah N
Shah S
Shera AS
Shu XO
Shuldiner AR
Sigurđsson G
Sijbrands E
Silveira A
Sim X
Sivapalaratnam S
Small KS
So WY
Stančáková A
Stefansson K
Steinbach G
Steinthorsdottir V
Stirrups K
Strawbridge RJ
Stringham HM
Sun Q
Suo C
Syvänen AC
Takayanagi R
Takeuchi F
Tay WT
Teslovich TM
Thorand B
Thorleifsson G
Thorsteinsdottir U
Tikkanen E
Trakalo J
Tremoli E
Trip MD
Tsai FJ
Tuomi T
Tuomilehto J
Uitterlinden AG
Valladares-Salgado A
Vedantam S
Veglia F
Voight BF
Wang C
Wareham NJ
Wennauer R
Wickremasinghe AR
Wilsgaard T
Wilson JF
Wiltshire S
Winckler W
Wong TY
Wood AR
Wu JY
Wu Y
Yamamoto K
Yamauchi T
Yang M
Yengo L
Yokota M
Young R
Zabaneh D
Zhang F
Zhang R
Zheng W
Zimmet PZ
Altshuler D
Bowden DW
Cho YS
Cox NJ
Cruz M
Hanis CL
Kooner J
Lee JY
Seielstad M
Teo YY
Boehnke M
Parra EJ
Chambers JC
Tai ES
McCarthy MI
Morris AP; Pokaż więcej
Corporate Authors:: DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium
Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium
South Asian Type 2 Diabetes (SAT2D) Consortium
Mexican American Type 2 Diabetes (MAT2D) Consortium
Type 2 Diabetes Genetic Exploration by Nex-generation sequencing in muylti-Ethnic Samples (T2D-GENES) Consortium
Źródło:: Nature genetics [Nat Genet] 2014 Mar; Vol. 46 (3), pp. 234-44. Date of Electronic Publication: 2014 Feb 09.
Typ publikacji:: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus, Type 2/*genetics
Alleles ; Asian People/genetics ; Case-Control Studies ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Hispanic or Latino/genetics ; Humans ; Polymorphism, Single Nucleotide ; Risk Factors ; White People/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Atrial natriuretic peptide and type 2 diabetes development--biomarker and genotype association study.
Autorzy:: Jujić A; Department of Heart Failure and Valvular Disease, Skåne University Hospital, Malmö, Sweden ; Department of Clinical Sciences, Lund University, Malmö, Sweden.
Nilsson PM; Department of Clinical Sciences, Lund University, Malmö, Sweden ; Center of Emergency Medicine, Skåne University Hospital, Malmö, Sweden.
Engström G; Department of Clinical Sciences, Lund University, Malmö, Sweden.
Hedblad B; Department of Clinical Sciences, Lund University, Malmö, Sweden.
Melander O; Department of Clinical Sciences, Lund University, Malmö, Sweden ; Center of Emergency Medicine, Skåne University Hospital, Malmö, Sweden.
Magnusson M; Department of Heart Failure and Valvular Disease, Skåne University Hospital, Malmö, Sweden ; Department of Clinical Sciences, Lund University, Malmö, Sweden.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Feb 19; Vol. 9 (2), pp. e89201. Date of Electronic Publication: 2014 Feb 19 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Atrial Natriuretic Factor/*genetics
Diabetes Mellitus, Type 2/*epidemiology
Diabetes Mellitus, Type 2/*genetics
Age Factors ; Atrial Natriuretic Factor/blood ; Body Mass Index ; Diabetes Mellitus, Type 2/metabolism ; Female ; Genotype ; Humans ; Male ; Polymorphism, Single Nucleotide/genetics ; Proportional Hazards Models ; Regression Analysis ; Sex Factors ; Sweden/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: The association between dietary energy density and type 2 diabetes in Europe: results from the EPIC-InterAct Study.
Autorzy:: van den Berg SW
van der A DL
Spijkerman AM
van Woudenbergh GJ
Tijhuis MJ
Amiano P
Ardanaz E
Beulens JW
Boeing H
Clavel-Chapelon F
Crowe FL
de Lauzon-Guillain B
Fagherazzi G
Franks PW
Freisling H
Gonzalez C
Grioni S
Halkjaer J
Huerta JM
Huybrechts I
Kaaks R
Khaw KT
Masala G
Nilsson PM
Overvad K
Panico S
Quirós JR
Rolandsson O
Sacerdote C
Sánchez MJ
Schulze MB
Slimani N
Struijk EA
Tjonneland A
Tumino R
Sharp SJ
Langenberg C
Forouhi NG
Feskens EJ
Riboli E
Wareham NJ; Pokaż więcej
Corporate Authors:: InterAct Consortium
Źródło:: PloS one [PLoS One] 2013 May 16; Vol. 8 (5), pp. e59947. Date of Electronic Publication: 2013 May 16 (Print Publication: 2013).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Energy Intake*
Diabetes Mellitus, Type 2/*epidemiology
Case-Control Studies ; Diet ; Europe ; Humans ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes.
Autorzy:: Morris AP; Wellcome Trust Centre for Human Genetics, University of Oxford, UK. />Voight BF
Teslovich TM
Ferreira T
Segrè AV
Steinthorsdottir V
Strawbridge RJ
Khan H
Grallert H
Mahajan A
Prokopenko I
Kang HM
Dina C
Esko T
Fraser RM
Kanoni S
Kumar A
Lagou V
Langenberg C
Luan J
Lindgren CM
Müller-Nurasyid M
Pechlivanis S
Rayner NW
Scott LJ
Wiltshire S
Yengo L
Kinnunen L
Rossin EJ
Raychaudhuri S
Johnson AD
Dimas AS
Loos RJ
Vedantam S
Chen H
Florez JC
Fox C
Liu CT
Rybin D
Couper DJ
Kao WH
Li M
Cornelis MC
Kraft P
Sun Q
van Dam RM
Stringham HM
Chines PS
Fischer K
Fontanillas P
Holmen OL
Hunt SE
Jackson AU
Kong A
Lawrence R
Meyer J
Perry JR
Platou CG
Potter S
Rehnberg E
Robertson N
Sivapalaratnam S
Stančáková A
Stirrups K
Thorleifsson G
Tikkanen E
Wood AR
Almgren P
Atalay M
Benediktsson R
Bonnycastle LL
Burtt N
Carey J
Charpentier G
Crenshaw AT
Doney AS
Dorkhan M
Edkins S
Emilsson V
Eury E
Forsen T
Gertow K
Gigante B
Grant GB
Groves CJ
Guiducci C
Herder C
Hreidarsson AB
Hui J
James A
Jonsson A
Rathmann W
Klopp N
Kravic J
Krjutškov K
Langford C
Leander K
Lindholm E
Lobbens S
Männistö S
Mirza G
Mühleisen TW
Musk B
Parkin M
Rallidis L
Saramies J
Sennblad B
Shah S
Sigurðsson G
Silveira A
Steinbach G
Thorand B
Trakalo J
Veglia F
Wennauer R
Winckler W
Zabaneh D
Campbell H
van Duijn C
Uitterlinden AG
Hofman A
Sijbrands E
Abecasis GR
Owen KR
Zeggini E
Trip MD
Forouhi NG
Syvänen AC
Eriksson JG
Peltonen L
Nöthen MM
Balkau B
Palmer CN
Lyssenko V
Tuomi T
Isomaa B
Hunter DJ
Qi L
Shuldiner AR
Roden M
Barroso I
Wilsgaard T
Beilby J
Hovingh K
Price JF
Wilson JF
Rauramaa R
Lakka TA
Lind L
Dedoussis G
Njølstad I
Pedersen NL
Khaw KT
Wareham NJ
Keinanen-Kiukaanniemi SM
Saaristo TE
Korpi-Hyövälti E
Saltevo J
Laakso M
Kuusisto J
Metspalu A
Collins FS
Mohlke KL
Bergman RN
Tuomilehto J
Boehm BO
Gieger C
Hveem K
Cauchi S
Froguel P
Baldassarre D
Tremoli E
Humphries SE
Saleheen D
Danesh J
Ingelsson E
Ripatti S
Salomaa V
Erbel R
Jöckel KH
Moebus S
Peters A
Illig T
de Faire U
Hamsten A
Morris AD
Donnelly PJ
Frayling TM
Hattersley AT
Boerwinkle E
Melander O
Kathiresan S
Nilsson PM
Deloukas P
Thorsteinsdottir U
Groop LC
Stefansson K
Hu F
Pankow JS
Dupuis J
Meigs JB
Altshuler D
Boehnke M
McCarthy MI; Pokaż więcej
Corporate Authors:: Wellcome Trust Case Control Consortium
Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators
Genetic Investigation of ANthropometric Traits (GIANT) Consortium
Asian Genetic Epidemiology Network–Type 2 Diabetes (AGEN-T2D) Consortium
South Asian Type 2 Diabetes (SAT2D) Consortium
DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium
Źródło:: Nature genetics [Nat Genet] 2012 Sep; Vol. 44 (9), pp. 981-90. Date of Electronic Publication: 2012 Aug 12.
Typ publikacji:: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Genetic Predisposition to Disease*/genetics
Diabetes Mellitus, Type 2/*genetics
Genome-Wide Association Study/*statistics & numerical data
Case-Control Studies ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Genes/physiology ; Humans ; Linkage Disequilibrium ; Male ; Pakistan/epidemiology ; Polymorphism, Single Nucleotide/physiology ; Sex Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Dietary fiber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus.
Autorzy:: Burger KN; University Medical Center, Utrecht, The Netherlands.
Beulens JW
van der Schouw YT
Sluijs I
Spijkerman AM
Sluik D
Boeing H
Kaaks R
Teucher B
Dethlefsen C
Overvad K
Tjønneland A
Kyrø C
Barricarte A
Bendinelli B
Krogh V
Tumino R
Sacerdote C
Mattiello A
Nilsson PM
Orho-Melander M
Rolandsson O
Huerta JM
Crowe F
Allen N
Nöthlings U; Pokaż więcej
Źródło:: PloS one [PLoS One] 2012; Vol. 7 (8), pp. e43127. Date of Electronic Publication: 2012 Aug 23.
Typ publikacji:: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus, Type 2/*mortality
Dietary Carbohydrates/*analysis
Dietary Carbohydrates/*pharmacology
Dietary Fiber/*analysis
Dietary Fiber/*pharmacology
Adult ; Aged ; Body Mass Index ; Cardiovascular Diseases/complications ; Cardiovascular Diseases/mortality ; Cardiovascular Diseases/physiopathology ; Cohort Studies ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/physiopathology ; Female ; Glycemic Index/drug effects ; Humans ; Male ; Middle Aged ; Risk ; Smoking

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: a cross-sectional analysis within the Malmö Preventive Project.
Autorzy:: Leosdottir M; Department of Cardiology, Skåne University Hospital, and Heart Health Group Department of Clinical Sciences, Lund University, Malmö, Sweden. />Willenheimer R
Persson M
Nilsson PM; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2011 Dec 28; Vol. 10, pp. 118. Date of Electronic Publication: 2011 Dec 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Health Status*
Cardiovascular Diseases/*epidemiology
Diabetes Complications/*epidemiology
Diabetes Mellitus, Type 1/*epidemiology
Diabetes Mellitus, Type 2/*epidemiology
Age Factors ; Aged ; Aged, 80 and over ; Cross-Sectional Studies ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Odds Ratio ; Risk Assessment ; Risk Factors ; Self Report ; Sex Factors ; Sweden/epidemiology